![Illustration of the four biliary drainage procedures in the PUMa trial.... | Download Scientific Diagram Illustration of the four biliary drainage procedures in the PUMa trial.... | Download Scientific Diagram](https://www.researchgate.net/publication/364824198/figure/fig1/AS:11431281093330449@1667203551163/Illustration-of-the-four-biliary-drainage-procedures-in-the-PUMa-trial-1A-PTBD-with.jpg)
Illustration of the four biliary drainage procedures in the PUMa trial.... | Download Scientific Diagram
![Female puma (Puma concolor) in shrubland of site 1 during high food... | Download Scientific Diagram Female puma (Puma concolor) in shrubland of site 1 during high food... | Download Scientific Diagram](https://www.researchgate.net/publication/325404799/figure/fig2/AS:642893039538183@1530289053852/Female-puma-Puma-concolor-in-shrubland-of-site-1-during-high-food-trial-4-April.png)
Female puma (Puma concolor) in shrubland of site 1 during high food... | Download Scientific Diagram
![Puma Biotechnology Presents P-II (SUMMIT) Basket Trial Results of Neratinib for EGFR Exon 18-Mutant NSCLC at EORTC/NCI/AACR 2022 Puma Biotechnology Presents P-II (SUMMIT) Basket Trial Results of Neratinib for EGFR Exon 18-Mutant NSCLC at EORTC/NCI/AACR 2022](https://pharmashots.com/public/images/20221028165227_original_6.webp)
Puma Biotechnology Presents P-II (SUMMIT) Basket Trial Results of Neratinib for EGFR Exon 18-Mutant NSCLC at EORTC/NCI/AACR 2022
Oxford Psychiatry on X: "Exciting developments on the new PUMA project with investigators holding their first meeting this week. PUMA, funded by @wellcome, is a multi-arm multi-stage (MAMS) platform trial for early
![Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS | Business Wire Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS | Business Wire](https://mms.businesswire.com/media/20191213005405/en/763006/5/4165450_121319_SABCS_2019_CONTROL_P5-14_Chan__poster_12-Dec-2019_FINAL.jpg)